Tag Archives: Biotech and the flu

Implementing the WHO PIP Framework – Industry’s Role & Outlook


In May 2011, the World Health Organization (WHO) adopted the Pandemic Influenza Preparedness (PIP) Framework after nearly five years of contentious negotiations. As noted by Anne Huvos, WHO Secretariat, the two objectives of the PIP Framework are: (1) to improve sharing of influenza viruses with human pandemic potential; and (2) to achieve more predictable, efficient, and equitable access to benefits, such as vaccines and antiviral medicines, during future pandemics. The subject of a session at Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

Biotech and the flu pandemic

Biotechnology researchers are working to create new vaccination options to help stop the next big pandemic before it starts.  Join Dr. Targan of BIO’s BioBytes as he walks us through the current steps in vaccine production, and what biotechnology is doing to help create new vaccines in quicker timeframes to help meet the global demand (click link below for video). For those of you attending the 8th Annual BIO Investor Forum this week in San Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , ,